top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
COC483
Colon cancer tissue array, set 3, 16 cases, 48 cores, non-over lapping with COC481 and COC482, one normal colon tissue corepaired with two tumor tissue cores from each patient, with grading and TNM staging data.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$252
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
TNM Classification: Colon and Rectum Carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - metastasis in 4 or more regional lymph nodes
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis
Human
16
48
2.0mm
4um
6
8
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for normal vs cancer IHC or ISH based protein or RNA tissue profiling in colon cancers.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 59 | Intestine, colon | Adenocarcinoma | I~II | T2N1M1 | |
A02 | M | 56 | Intestine, colon | Adenocarcinoma | II | T3N1M0 | |
A03 | F | 42 | Intestine, colon | Adenocarcinoma | II | T3N0M0 | |
A04 | F | 86 | Intestine, colon | Adenocarcinoma | II | T3N0M0 | |
A05 | M | 79 | Intestine, colon | Adenocarcinoma | II | T3N0M0 | |
A06 | M | 52 | Intestine, colon | Adenocarcinoma | II | T2N0M0 | |
A07 | M | 46 | Intestine, colon | Adenocarcinoma | II | T3N2M0 | |
A08 | M | 68 | Intestine, colon | Adenocarcinoma | II | T3N0M0 | |
B01 | M | 59 | Intestine, colon | Adenocarcinoma | I~II | T2N1M1 | |
B02 | M | 56 | Intestine, colon | Adenocarcinoma | II | T3N1M0 | |
B03 | F | 42 | Intestine, colon | Adenocarcinoma | II | T3N0M0 | |
B04 | F | 86 | Intestine, colon | Adenocarcinoma | II | T3N0M0 | |
B05 | M | 79 | Intestine, colon | Adenocarcinoma | II | T3N0M0 | |
B06 | M | 52 | Intestine, colon | Adenocarcinoma | II | T2N0M0 | |
B07 | M | 46 | Intestine, colon | Adenocarcinoma | II | T3N2M0 | |
B08 | M | 68 | Intestine, colon | Adenocarcinoma | II | T3N0M0 | |
C01 | M | 59 | Intestine, colon | Uninvolved colon tissue of A1,B1 | |||
C02 | M | 56 | Intestine, colon | Uninvolved colon tissue of A2,B2 | |||
C03 | F | 42 | Intestine, colon | Uninvolved colon tissue of A3,B3 | |||
C04 | F | 86 | Intestine, colon | Uninvolved colon tissue of A4,B4 | |||
C05 | M | 79 | Intestine, colon | Uninvolved colon tissue of A5,B5 | |||
C06 | M | 52 | Intestine, colon | Uninvolved colon tissue of A6,B6 | |||
C07 | M | 46 | Intestine, colon | Uninvolved colon tissue of A7,B7 | |||
C08 | M | 68 | Intestine, colon | Uninvolved colon tissue of A8,B8 | |||
D01 | F | 57 | Intestine, colon | Adenocarcinoma | II | T3N0M0 | |
D02 | F | 76 | Intestine, colon | Adenocarcinoma | II~III | T2N0M0 | |
D03 | M | 49 | Intestine, colon | Adenocarcinoma | II~III | T3N0M0 | |
D04 | M | 57 | Intestine, colon | Mucinous adenocarcinoma | T3N1M0 | ||
D05 | M | 77 | Intestine, colon | Signet ring cell carcinoma | T3N2M0 | ||
D06 | M | 35 | Intestine, colon | Signet ring cell carcinoma | T3N0M0 | ||
D07 | M | 57 | Intestine, colon | Squamous cell carcinoma | II | T3N0M0 | |
D08 | M | 73 | Intestine, colon | Carcinoid | T3N0M0 | ||
E01 | F | 57 | Intestine, colon | Adenocarcinoma | II | T3N0M0 | |
E02 | F | 76 | Intestine, colon | Adenocarcinoma | II~III | T2N0M0 | |
E03 | M | 49 | Intestine, colon | Adenocarcinoma | II~III | T3N0M0 | |
E04 | M | 57 | Intestine, colon | Mucinous adenocarcinoma | T3N1M0 | ||
E05 | M | 77 | Intestine, colon | Signet ring cell carcinoma | T3N2M0 | ||
E06 | M | 35 | Intestine, colon | Signet ring cell carcinoma | T3N0M0 | ||
E07 | M | 57 | Intestine, colon | Squamous cell carcinoma | II | T3N0M0 | |
E08 | M | 73 | Intestine, colon | Carcinoid | T3N0M0 | ||
F01 | F | 57 | Intestine, colon | Uninvolved colon tissue of D1,E1 | |||
F02 | F | 76 | Intestine, colon | Uninvolved colon tissue of D2,E2 | |||
F03 | M | 49 | Intestine, colon | Uninvolved colon tissue of D3,E3 | |||
F04 | M | 57 | Intestine, colon | Uninvolved colon tissue of D4,E4 | |||
F05 | M | 77 | Intestine, colon | Uninvolved colon tissue of D5,E5 | |||
F06 | M | 35 | Intestine, colon | Uninvolved colon tissue of D6,E6 | |||
F07 | M | 57 | Intestine, colon | Uninvolved colon tissue of D7,E7 | |||
F08 | M | 73 | Intestine, colon | Uninvolved colon tissue of D8,E8 | |||
null |
bottom of page